Prognosis
White House Seeks to Cut Xylazine Supply in Plan to Curb Deaths
- Plan aims to reduce xylazine-positive deaths by 15% in 2 years
- Overdose deaths linked to animal sedative have soared
This article is for subscribers only.
The White House has developed a new strategy to reduce the growing number of overdose deaths linked to xylazine, a potent animal sedative that’s increasingly being combined with opioids and other drugs.
President Joe Biden’s administration will work to curb the distribution of xylazine, which officials have said is fairly easy to obtain, among other steps, according to a plan released Tuesday. The White House is seeking to reduce xylazine-related fatalities by 15% in at least three of the four US census regions by 2025.